ESMO E-Learning and V-Learning
Watch E-Learning and V-Learning webcasts produced by leading oncology experts and take the CME test.
ESMO continually develops E-Learning and V-Learning modules covering a broad range of topics relevant for practising oncologists including:
- Recent discoveries and their impact on current treatments for diverse tumour types
- Oncology clinical case studies and conundrums
- Guidance on implementation of the latest ESMO clinical practise guidelines and incorporation of recent clinical advancements
- Selected oncology highlights from the past year
E-Learning and V-Learning modules less than 2 years are accompanied by a CME test (ESMO members only) awarding 1 ESMO-MORA category 1 point and 1 ACOE (Accreditation Council of Oncology in EU) CME credit on successful completion. ESMO members have the option to print the certificate immediately or store in the myESMO CME bank.
Modules marked as V-Learning contain video presentations to enhance your learning experience.
ESMO E-Learning and V-Learning Modules are the original property of ESMO. Authorship is retained by the module authors. The modules and their constituent slides can not be presented in any form, modified or otherwise, on a platform other than those belonging to ESMO, without prior explicit permission from ESMO. Module PDF files are available for individual download by medical professionals for study and reference purposes only.
|Breast Cancer - Personalised Medicine - Translational Research||Metabolomics in Cancer, With a Focus on Breast Cancer||Christopher Hart, Angelo Di Leo|
|Biomarkers||The Use of Biomarkers for Treatment Decisions in Oncology||Timothy Yap, Debra Josephs|
|Anti-Cancer Agents & Biologic Therapy - Ovarian Cancer||Management of BRCA Mutated Ovarian Cancer||Jonathan Ledermann|
|Anti-Cancer Agents & Biologic Therapy - Central Nervous System Malignancies - Surgery and/or Radiotherapy of Cancer||Multidisciplinary Treatment for Glioblastoma||Matthias Preusser|
|Anti-Cancer Agents & Biologic Therapy - Cancer Immunology and Immunotherapy - Gastric Cancer||Advances in Gastric Cancer: Biology and Treatment for Advanced Disease||Andrés Cervantes|
|Anti-Cancer Agents & Biologic Therapy - Gastric Cancer - Surgery and/or Radiotherapy of Cancer||Advances in Gastric Cancer: How to Approach Localised Disease||Andrés Cervantes|
|Breast Cancer - Imaging, Diagnosis and Staging - Biomarkers||Imaging Biomarkers in Breast Oncology Practice||Elizabeth O’Flynn|
|Colon Cancer - Rectal Cancer - Biomarkers||Validated and Promising Predictive Factors in mCRC: Recent Updates on RAS Testing||Fotios Loupakis|
|Pathology/Molecular Biology - Personalised Medicine - Translational Research||Next-Generation Histopathological Diagnosis for Precision Medicine in Solid Cancers||Aldo Scarpa|
|Personalised Medicine||V-Learning: Tumour Heterogeneity in the Clinic||Philippe Bedard|
|Geriatric Oncology - Non-Small-Cell Lung Cancer, Metastatic||Treatment of Advanced NSCLC in the Elderly||Cesare Gridelli|
|Anti-Cancer Agents & Biologic Therapy - Non-Small-Cell Lung Cancer, Metastatic||Management of Advanced NSCLC: Cisplatin or Carboplatin Combination Therapies||Marina Garassino, Italy, Antonio Rossi|
|Non-Small-Cell Lung Cancer, Metastatic - Pathology/Molecular Biology - Translational Research||Important Pathways to Target in (Advanced) NSCLC: A Focus on ALK, EGFR-Inhibition and Anti-Angiogenesis and their Implications for Clinical Practice||Morena Fasano, Floriana Morgillo|
|Pathology/Molecular Biology - Translational Research||PI3K/Akt/mTOR Pathway||Massimo Broggini, Elisa Caiola|
|Neuroendocrine Cancers||Overview on Management of Neuroendocrine Tumours of Gastrointestinal Tract||Ramon Salazar|